Mastologia

Artigos em destaque

18F-FDG PET/CT for early prediction of pathological complete response in breast cancer neoadjuvant therapy: a retrospective analysis.
The oncologist. 2024 Jul; doi: 10.1093/oncolo/oyae185. pii: oyae185. Base : PUBMED
- Atualizado em 25/07/2024

Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer.
Annals of surgical oncology. 2024 Jul; doi: 10.1245/s10434-024-15638-6. pii: . Base : PUBMED
- Atualizado em 24/07/2024

Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Jul; 22(Jul):331-357. doi: 10.6004/jnccn.2024.0035. pii: . Base : PUBMED
- Atualizado em 24/07/2024

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).
Breast (Edinburgh, Scotland). 2024 Aug; 76(Aug):103756. doi: 10.1016/j.breast.2024.103756. pii: 103756. Base : PUBMED
- Atualizado em 24/07/2024

Intensity Modulated Therapy for Patients With Breast Cancer. Practical Guidelines and Tips for an Effective Treatment Planning Strategy.
Advances in radiation oncology. 2024 Aug; 9(Aug):101535. doi: 10.1016/j.adro.2024.101535. pii: 101535. Base : PUBMED
- Atualizado em 24/07/2024

Digital breast tomosynthesis for breast cancer diagnosis in women with dense breasts and additional breast cancer risk factors: A systematic review.
Breast (Edinburgh, Scotland). 2024 Jul; 77(Jul):103767. doi: 10.1016/j.breast.2024.103767. pii: S0960-9776(24)00098-5. Base : PUBMED
- Atualizado em 24/07/2024

Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline.
Practical radiation oncology. 2024 ; 14():112-132. doi: 10.1016/j.prro.2023.11.001. pii: S1879-8500(23)00296-5. Base : PUBMED
- Atualizado em 24/07/2024

Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities.
Annals of surgical oncology. 2024 Jul; doi: 10.1245/s10434-024-15713-y. pii: . Base : PUBMED
- Atualizado em 24/07/2024

HER2-targeted therapies beyond breast cancer - an update.
Nature reviews. Clinical oncology. 2024 Jul; doi: 10.1038/s41571-024-00924-9. pii: . Base : PUBMED
- Atualizado em 24/07/2024

Risk factors for residual fibroglandular breast tissue following a mastectomy - an overview and retrospective cohort study.
BMC cancer. 2024 Jul; 24(Jul):856. doi: 10.1186/s12885-024-12491-4. pii: 856. Base : PUBMED
- Atualizado em 24/07/2024

Optimizing Postneoadjuvant Treatment in Patients With Early Breast Cancer Achieving Pathologic Complete Response.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Jul; 42(Jul):2372-2376. doi: 10.1200/JCO.23.01935. pii: . Base : PUBMED
- Atualizado em 11/07/2024

Nonneoplastic and neoplastic sclerosing lesions of the breast.
Histopathology. 2024 Jun; doi: 10.1111/his.15252. pii: . Base : PUBMED
- Atualizado em 01/07/2024

Characteristics and risk factors of axillary lymph node metastasis of microinvasive breast cancer.
Breast cancer research and treatment. 2024 Apr; doi: 10.1007/s10549-024-07305-x. pii: . Base : PUBMED
- Atualizado em 28/06/2024

Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment.
Lancet (London, England). 2024 Jun; 403(Jun):2734-2746. doi: 10.1016/S0140-6736(24)00425-2. pii: S0140-6736(24)00425-2. Base : PUBMED
- Atualizado em 24/06/2024

Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2024 Jun; 331(Jun):1918-1930. doi: 10.1001/jama.2024.5534. pii: . Base : PUBMED
- Atualizado em 22/06/2024

Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Jun; 42(Jun):2233-2235. doi: 10.1200/JCO.24.00886. pii: . Base : PUBMED
- Atualizado em 21/06/2024

Breast Cancer Screening Recommendations for Transgender Patients: A Review.
Mayo Clinic proceedings. 2024 Apr; 99(Apr):630-639. doi: 10.1016/j.mayocp.2023.12.006. pii: S0025-6196(23)00607-9. Base : PUBMED
- Atualizado em 18/06/2024

Performance of MRI for standardized lymph nodes assessment in breast cancer: are we ready for Node-RADS?
European radiology. 2024 Jun; doi: 10.1007/s00330-024-10828-y. pii: . Base : PUBMED
- Atualizado em 17/06/2024

Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer.
Breast cancer research and treatment. 2024 Jun; doi: 10.1007/s10549-024-07386-8. pii: . Base : PUBMED
- Atualizado em 10/06/2024

Radial Scars on Screening Digital Breast Tomosynthesis: Upstaging Rates and Management Strategies.
AJR. American journal of roentgenology. 2024 Jun; 1-8. doi: 10.2214/AJR.24.30845. pii: . Base : PUBMED
- Atualizado em 10/06/2024

Guideline, consenso e protocolo

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).
Breast (Edinburgh, Scotland). 2024 Aug; 76(Aug):103756. doi: 10.1016/j.breast.2024.103756. pii: 103756. Base : PUBMED
- Atualizado em 24/07/2024

Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Feb; 42(Feb):584-604. doi: 10.1200/JCO.23.02225. pii: . Base : PUBMED
- Atualizado em 24/07/2024

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology. 2024 Feb; 35(Feb):159-182. doi: 10.1016/j.annonc.2023.11.016. pii: S0923-7534(23)05104-9. Base : PUBMED
- Atualizado em 28/05/2024

Challenges of breast cancer screening.
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2023 Sep; 45(Sep):551-554. doi: 10.1055/s-0043-1775931. pii: . Base : PUBMED
- Atualizado em 24/05/2024

Challenges of breast cancer screening.
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia. 2023 Oct; 45(Oct):622-625. doi: 10.1055/s-0043-1776716. pii: . Base : PUBMED
- Atualizado em 24/05/2024

NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.
Journal of the National Comprehensive Cancer Network : JNCCN. 2023 Sep; 21(Sep):900-909. doi: 10.6004/jnccn.2023.0046. pii: . Base : PUBMED
- Atualizado em 24/05/2024

New US breast cancer screening recommendations.
The Lancet. Oncology. 2023 Jun; 24(Jun):e242. doi: 10.1016/S1470-2045(23)00238-3. pii: S1470-2045(23)00238-3. Base : PUBMED
- Atualizado em 24/05/2024

European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2024 Jan; 50(Jan):107292. doi: 10.1016/j.ejso.2023.107292. pii: S0748-7983(23)00930-7. Base : PUBMED
- Atualizado em 17/05/2024

International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations.
The Lancet. Oncology. 2024 Feb; 25(Feb):e73-e83. doi: 10.1016/S1470-2045(23)00534-X. pii: S1470-2045(23)00534-X. Base : PUBMED
- Atualizado em 13/03/2024

NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
Journal of the National Comprehensive Cancer Network : JNCCN. 2023 Jun; 21(Jun):594-608. doi: 10.6004/jnccn.2023.0031. pii: . Base : PUBMED
- Atualizado em 31/01/2024

Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.
Annals of oncology : official journal of the European Society for Medical Oncology. 2023 Nov; 34(Nov):970-986. doi: 10.1016/j.annonc.2023.08.017. pii: S0923-7534(23)00835-9. Base : PUBMED
- Atualizado em 31/01/2024

Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper.
Clinical breast cancer. 2023 Oct; 23(Oct):e458-e469. doi: 10.1016/j.clbc.2023.07.006. pii: S1526-8209(23)00202-1. Base : PUBMED
- Atualizado em 31/01/2024

Recomendações do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem, da Sociedade Brasileira de Mastologia e da Federação Brasileira das Associações de Ginecologia e Obstetrícia para rastreamento do câncer de mama por métodos de imagem
Radiol Bras. 2023 Jul/Ago;56(4):207–214. Base : AMMG
- Atualizado em 30/01/2024

ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC).
Annals of oncology : official journal of the European Society for Medical Oncology. 2023 Oct; 34(Oct):849-866. doi: 10.1016/j.annonc.2023.08.001. pii: S0923-7534(23)00798-6. Base : PUBMED
- Atualizado em 26/01/2024

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology. 2023 Aug; 34(Aug):645-659. doi: 10.1016/j.annonc.2023.05.008. pii: S0923-7534(23)00693-2. Base : PUBMED
- Atualizado em 26/01/2024

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology. 2021 12; 32(12):1475-1495. doi: 10.1016/j.annonc.2021.09.019. pii: S0923-7534(21)04498-7. Base : PUBMED
- Atualizado em 16/01/2023

ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5).
Annals of oncology : official journal of the European Society for Medical Oncology. 2022 Nov; 33(Nov):1097-1118. doi: 10.1016/j.annonc.2022.07.007. pii: S0923-7534(22)01858-0. Base : PUBMED
- Atualizado em 02/12/2022

Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age.
Annals of surgical oncology. 2022 Aug; doi: 10.1245/s10434-022-12237-1. pii: . Base : PUBMED
- Atualizado em 06/09/2022

ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density.
Journal of the American College of Radiology : JACR. 2021 11; 18(11):S456-S473. doi: 10.1016/j.jacr.2021.09.002. pii: S1546-1440(21)00725-0. Base : PUBMED
- Atualizado em 10/08/2022

Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline.
Current oncology (Toronto, Ont.). 2022 04; 29(04):2599-2615. doi: 10.3390/curroncol29040213. pii: . Base : PUBMED
- Atualizado em 10/08/2022

feed

18F-FDG PET/CT for early prediction of pathological complete response in breast cancer neoadjuvant therapy: a retrospective analysis.
The oncologist. 2024 Jul; doi: 10.1093/oncolo/oyae185. pii: oyae185. Base: PUBMED
- Atualizado em 25/07/2024

Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer.
Annals of surgical oncology. 2024 Jul; doi: 10.1245/s10434-024-15638-6. pii: . Base: PUBMED
- Atualizado em 24/07/2024

Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
Annals of surgical oncology. 2024 Jul; doi: 10.1245/s10434-024-15708-9. pii: . Base: PUBMED
- Atualizado em 24/07/2024

Randomized trials of estrogen-alone and breast cancer incidence: a meta-analysis.
Breast cancer research and treatment. 2024 Jul; 206(Jul):177-184. doi: 10.1007/s10549-024-07307-9. pii: . Base: PUBMED
- Atualizado em 24/07/2024

Digital breast tomosynthesis for breast cancer diagnosis in women with dense breasts and additional breast cancer risk factors: A systematic review.
Breast (Edinburgh, Scotland). 2024 Jul; 77(Jul):103767. doi: 10.1016/j.breast.2024.103767. pii: S0960-9776(24)00098-5. Base: PUBMED
- Atualizado em 24/07/2024

Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities.
Annals of surgical oncology. 2024 Jul; doi: 10.1245/s10434-024-15713-y. pii: . Base: PUBMED
- Atualizado em 24/07/2024

HER2-targeted therapies beyond breast cancer - an update.
Nature reviews. Clinical oncology. 2024 Jul; doi: 10.1038/s41571-024-00924-9. pii: . Base: PUBMED
- Atualizado em 24/07/2024

Risk factors for residual fibroglandular breast tissue following a mastectomy - an overview and retrospective cohort study.
BMC cancer. 2024 Jul; 24(Jul):856. doi: 10.1186/s12885-024-12491-4. pii: 856. Base: PUBMED
- Atualizado em 24/07/2024

Optimizing Postneoadjuvant Treatment in Patients With Early Breast Cancer Achieving Pathologic Complete Response.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Jul; 42(Jul):2372-2376. doi: 10.1200/JCO.23.01935. pii: . Base: PUBMED
- Atualizado em 11/07/2024